CX NEWS
CX 2018 in numbers
CX 2018 in numbersThis year's CX welcomed more than 4,000 participants at Olympia London from a record-breaking 86 countries. See the full stats and highlights in the video above.
CX showcases most promising vascular innovations
CX 2018 Dragons' Den winner, Kieran Murphy, with the Dragons The Innovation Showcase yesterday brought together the CX values of education, innovation, and evidence to paint a global picture of vascular entrepreneurship, [...]
One-year outcomes of EndoAnchor study adds ESAR—endosuture aneurysm repair—to the endovascular lexicon
Frank Arko Frank Arko (Charlotte, USA) presented one-year results from the 70-patient short-neck cohort of the ANCHOR Registry. Patients were treated with an endograft and endoanchors (Endurant and Heli-FX, Medtronic) for abdominal [...]
Low early mortality and high technical success for novel thoracic stent graft
A physician-sponsored investigational device exemption trial on thoracic endovascular aortic repair (TEVAR) using a new thoracic stent graft (Valiant thoracoabdominal aortic aneurysm stent graft, Medtronic), along with its initial 30-day data, was revealed at [...]
First case experience presented with next generation conformable EVAR device
CX delegates were presented data from the first 10 EVAR patients treated using a new conformable device, the Gore Excluder conformable abdominal aortic aneurysm endoprosthesis with active control system, yesterday. Robert Rhee (Brooklyn, New [...]
“Fantastic” live case demonstrates potential value of intravascular lithotripsy
In an exciting session yesterday, the CX audience witnessed the demonstration of a novel treatment strategy with intravascular lithotripsy for calcified arterial stenosis. It will now become a CX tradition to feature live cases [...]